| Bioactivity | NWP-0476 is BCL-2/BCL-xL inhibitor. NWP-0476 has a modified structure with fine-tuned BCL-xL activity. NWP-0476 can be used for relapsed T-acute lymphoblastic leukemia (T-ALL) research[1]. |
| Name | NWP-0476 |
| CAS | 2290611-26-4 |
| Formula | C47H53ClN8O8S |
| Molar Mass | 925.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Saygin C, et al. Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia. Clin Cancer Res. 2023 Aug 15;29(16):3151-3161. |
NWP-0476
CAS: 2290611-26-4 F: C47H53ClN8O8S W: 925.49
NWP-0476 is BCL-2/BCL-xL inhibitor. NWP-0476 has a modified structure with fine-tuned BCL-xL activity. NWP-0476 can be u
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.